MedPath

Prevena Vascular Groin Wound Study

Phase 4
Conditions
Wound Infection
Peripheral Arterial Disease
Aneurysm
Surgical Wound Dehiscence
Interventions
Device: Dry gauze dressing care
Device: Prevena Care
Registration Number
NCT02581904
Lead Sponsor
Thomas Jefferson University
Brief Summary

The purpose of this study is to determine if the application of a negative pressure dressing intraoperatively (Prevena; KCI, Inc) to vascular groin incisions decreases the wound complication rate in high risk patients.

Detailed Description

The study randomizes patients (1:1) considered high risk, according to a specific set of risk factors, for wound complications into standard post-op dressings vs. Prevena vacuum dressing. The wounds will then be assessed for wound complications in the 30 days postoperatively. Wound complications include breakdown, infection and lymph leak. Patients not considered high risk will have standard post-op dressings and followed similarly to controls. The investigators will also assess economic impact of negative pressure dressing on length of stay and overall inpatient costs.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • All patients undergoing a femoral incision during vascular reconstruction or repair will be considered for study
Exclusion Criteria
  • Emergency procedure
  • Unable to give informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low Risk - Dry Gauze Dressing CareDry gauze dressing careInitial dry gauze dressing will be placed sterile in the operating room and will be changed daily
High Risk - Dry Gauze Dressing CareDry gauze dressing careInitial dry gauze dressing will be placed sterile in the operating room and will be changed daily
High Risk - Prevena CarePrevena CareThe Prevena device is a product from KCI and is a sterile sponge that covers the closed incision. The device is placed sterile in the operating room and suction is then applied to the sponge for 5-7 days.
Primary Outcome Measures
NameTimeMethod
Groin Wound Complication30 days

Composite measure including wound dehiscence (skin or fascia), lymph leak (seroma or fistula), infection (deep or superficial), or hematoma

Secondary Outcome Measures
NameTimeMethod
Hospital Readmission30 days

Readmission for wound complication

Return to Operating Room30 days
Index Hospital Cost30 days
Hospital Length of stay30 days

Trial Locations

Locations (1)

Thomas Jefferson University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath